lcva2/iStock Editorial via Getty Images Abu Dhabi's ADNOC and Austria's OMV ( OMVJF ) said Thursday they agreed to delay the listing of a co-owned petrochemicals venture until at least next year, citing volatility from the Middle East war, Dow Jones reported. The companies said the formation of Borouge Group International—the combination of their petrochemicals businesses, ADNOC's Borouge and OMV'...
lcva2/iStock Editorial via Getty Images Abu Dhabi's ADNOC and Austria's OMV ( OMVJF ) said Thursday they agreed to delay the listing of a co-owned petrochemicals venture until at least next year, citing volatility from the Middle East war, Dow Jones reported. The companies said the formation of Borouge Group International—the combination of their petrochemicals businesses, ADNOC's Borouge and OMV's ( OMVJF ) Borealis, plus the subsequent acquisition of Nova Chemicals—is progressing according to plan and will be completed by the end of this month. The companies said they agreed to carry out a tender offer to convert shares of Borouge into Borouge Group International stock in 2027, subject to market conditions; Borouge Group will be privately held until then. ADNOC and OMV ( OMVJF ) agreed last year to create the business, forming a petrochemical giant with a combined value of ~$60B in an all-share deal. More on OMV OMV: Higher Oil Prices Boost Upside, But I Still See A Hold OMV Q4 2025 Earnings Call Presentation
Some notable increases to particular attractions were driven by particular events, such as the re-opening of the Salisbury Wing at the National Gallery, while Halloween or Christmas helped drive rises for venues such as Chatsworth, Kenwood House and Blenheim Palace.
Some notable increases to particular attractions were driven by particular events, such as the re-opening of the Salisbury Wing at the National Gallery, while Halloween or Christmas helped drive rises for venues such as Chatsworth, Kenwood House and Blenheim Palace.
phakphum patjangkata/iStock via Getty Images By Jennifer Nash New home sales unexpectedly sank to their lowest level since 2022 in January. According to the Census Bureau, new home sales were at a seasonally adjusted annual rate of 587,000 in January. This represents a 17.6% decline from December's rate of 712,000 and an 11.3% drop from the previous year. The latest reading was lower than the fore...
phakphum patjangkata/iStock via Getty Images By Jennifer Nash New home sales unexpectedly sank to their lowest level since 2022 in January. According to the Census Bureau, new home sales were at a seasonally adjusted annual rate of 587,000 in January. This represents a 17.6% decline from December's rate of 712,000 and an 11.3% drop from the previous year. The latest reading was lower than the forecast of 722,000. For a long-term perspective, here is a snapshot of the series beginning in 1963. We've included a six-month moving average to highlight the trend in this highly volatile series. For a closer look, the next chart shows new home sales since 1990. Over this time frame, we see the steady rise in new home sales following the early-90s recession and the acceleration in sales during the real estate bubble that peaked in 2005. Starting in 2011, there was a similar rise in new home sales that peaked near the end of 2020 and retracted for about two years. New home sales showed consistent growth at the start of 2023 but have been stagnant over the past couple of years. New Home Sales: The Population-Adjusted Reality Simply looking at raw new home sales figures can be misleading, as a growing population naturally suggests a higher number of sales. To gain a clearer picture of housing market strength relative to population growth, we need to normalize the data with a simple population adjustment. This adjustment - expressing new home sales as a percentage of the population - allows us to see the proportion of the population actively purchasing new homes, effectively accounting for the increase in potential buyers. This reveals whether housing demand is truly keeping pace with population growth. The Census Bureau's mid-month population estimates show an 82.1% increase in the U.S. population since 1963. Here is a chart of new home sales as a percentage of the population. This adjusted data reveals key trends. A rising percentage indicates a healthy market with increased d...
Iran can also use geography of the strait to its advantage. Not only is the strait narrow and shallow, the coastline is also mountainous. This allows Iran to launch elevated attacks, which ships have less time to react to.
Iran can also use geography of the strait to its advantage. Not only is the strait narrow and shallow, the coastline is also mountainous. This allows Iran to launch elevated attacks, which ships have less time to react to.
"It used to be so much easier to find all the items for Nowruz before. Now, if you go anywhere, you're always worried whether you will be caught up in an air strike or not," says Parmis, a woman in her 20s who lives in Tehran.
"It used to be so much easier to find all the items for Nowruz before. Now, if you go anywhere, you're always worried whether you will be caught up in an air strike or not," says Parmis, a woman in her 20s who lives in Tehran.
Fintel reports that on March 19, 2026, Clear Street initiated coverage of Rocket Lab (NasdaqCM:RKLB) with a Buy recommendation. Analyst Price Forecast Suggests 19.15% Upside As of February 25, 2026, the average one-year price target for Rocket Lab is $85.59/share. The forecasts range from a low of $55.55 to a high of $126.00. The average price target represents an increase of 19.15% from its lates...
Fintel reports that on March 19, 2026, Clear Street initiated coverage of Rocket Lab (NasdaqCM:RKLB) with a Buy recommendation. Analyst Price Forecast Suggests 19.15% Upside As of February 25, 2026, the average one-year price target for Rocket Lab is $85.59/share. The forecasts range from a low of $55.55 to a high of $126.00. The average price target represents an increase of 19.15% from its latest reported closing price of $71.83 / share. See our leaderboard of companies with the largest price target upside. The projected annual revenue for Rocket Lab is 732MM, an increase of 21.71%. The projected annual non-GAAP EPS is -0.22. What is the Fund Sentiment? There are 921 funds or institutions reporting positions in Rocket Lab. This is an decrease of 62 owner(s) or 6.31% in the last quarter. Average portfolio weight of all funds dedicated to RKLB is 0.22%, an increase of 38.34%. Total shares owned by institutions decreased in the last three months by 9.82% to 282,679K shares. The put/call ratio of RKLB is 0.71, indicating a bullish outlook. What are Other Shareholders Doing? Baillie Gifford holds 17,851K shares representing 3.14% ownership of the company. In its prior filing, the firm reported owning 12,126K shares , representing an increase of 32.07%. The firm increased its portfolio allocation in RKLB by 140.47% over the last quarter. Capital World Investors holds 16,201K shares representing 2.85% ownership of the company. In its prior filing, the firm reported owning 14,462K shares , representing an increase of 10.73%. The firm increased its portfolio allocation in RKLB by 62.39% over the last quarter. Jpmorgan Chase holds 9,695K shares representing 1.70% ownership of the company. In its prior filing, the firm reported owning 5,573K shares , representing an increase of 42.52%. The firm increased its portfolio allocation in RKLB by 165.44% over the last quarter. Geode Capital Management holds 9,005K shares representing 1.58% ownership of the company. In its prior fil...
Fintel reports that on March 19, 2026, Truist Securities initiated coverage of Inventiva S.A. - Depositary Receipt (NasdaqGM:IVA) with a Buy recommendation. Analyst Price Forecast Suggests 160.87% Upside As of February 24, 2026, the average one-year price target for Inventiva S.A. - Depositary Receipt is $15.80/share. The forecasts range from a low of $8.43 to a high of $27.97. The average price t...
Fintel reports that on March 19, 2026, Truist Securities initiated coverage of Inventiva S.A. - Depositary Receipt (NasdaqGM:IVA) with a Buy recommendation. Analyst Price Forecast Suggests 160.87% Upside As of February 24, 2026, the average one-year price target for Inventiva S.A. - Depositary Receipt is $15.80/share. The forecasts range from a low of $8.43 to a high of $27.97. The average price target represents an increase of 160.87% from its latest reported closing price of $6.06 / share. See our leaderboard of companies with the largest price target upside. The projected annual revenue for Inventiva S.A. - Depositary Receipt is 124MM, an increase of 629.23%. The projected annual non-GAAP EPS is -1.35. What is the Fund Sentiment? There are 59 funds or institutions reporting positions in Inventiva S.A. - Depositary Receipt. This is an increase of 35 owner(s) or 145.83% in the last quarter. Average portfolio weight of all funds dedicated to IVA is 0.97%, an increase of 432.02%. Total shares owned by institutions increased in the last three months by 813.85% to 46,711K shares. What are Other Shareholders Doing? Samsara BioCapital holds 5,195K shares. Paradigm Biocapital Advisors holds 4,000K shares. ADAR1 Capital Management holds 2,710K shares. Trails Edge Capital Partners holds 2,658K shares. Millennium Management holds 2,653K shares. In its prior filing, the firm reported owning 112K shares , representing an increase of 95.78%. The firm increased its portfolio allocation in IVA by 1,773.57% over the last quarter. Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds. Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved...
Fintel reports that on March 19, 2026, Truist Securities upgraded their outlook for Tandem Diabetes Care (NasdaqGM:TNDM) from Hold to Buy. Analyst Price Forecast Suggests 20.61% Upside As of February 25, 2026, the average one-year price target for Tandem Diabetes Care is $29.72/share. The forecasts range from a low of $21.21 to a high of $58.80. The average price target represents an increase of 2...
Fintel reports that on March 19, 2026, Truist Securities upgraded their outlook for Tandem Diabetes Care (NasdaqGM:TNDM) from Hold to Buy. Analyst Price Forecast Suggests 20.61% Upside As of February 25, 2026, the average one-year price target for Tandem Diabetes Care is $29.72/share. The forecasts range from a low of $21.21 to a high of $58.80. The average price target represents an increase of 20.61% from its latest reported closing price of $24.64 / share. See our leaderboard of companies with the largest price target upside. The projected annual revenue for Tandem Diabetes Care is 1,133MM, an increase of 11.65%. The projected annual non-GAAP EPS is 0.01. What is the Fund Sentiment? There are 328 funds or institutions reporting positions in Tandem Diabetes Care. This is an decrease of 173 owner(s) or 34.53% in the last quarter. Average portfolio weight of all funds dedicated to TNDM is 0.09%, an increase of 9.20%. Total shares owned by institutions decreased in the last three months by 17.16% to 76,456K shares. The put/call ratio of TNDM is 0.66, indicating a bullish outlook. What are Other Shareholders Doing? Sessa Capital IM holds 5,000K shares representing 7.32% ownership of the company. No change in the last quarter. ArrowMark Colorado Holdings holds 2,890K shares representing 4.23% ownership of the company. In its prior filing, the firm reported owning 3,691K shares , representing a decrease of 27.74%. The firm increased its portfolio allocation in TNDM by 67.95% over the last quarter. GW&K Investment Management holds 2,675K shares representing 3.92% ownership of the company. No change in the last quarter. VEXPX - VANGUARD EXPLORER FUND Investor Shares holds 2,127K shares representing 3.11% ownership of the company. In its prior filing, the firm reported owning 1,998K shares , representing an increase of 6.06%. The firm decreased its portfolio allocation in TNDM by 6.62% over the last quarter. Citadel Advisors holds 2,089K shares representing 3.06% ownership...
Fintel reports that on March 19, 2026, B. Riley Securities initiated coverage of FrontView REIT (NYSE:FVR) with a Buy recommendation. Analyst Price Forecast Suggests 4.27% Upside As of February 25, 2026, the average one-year price target for FrontView REIT is $16.90/share. The forecasts range from a low of $14.14 to a high of $19.95. The average price target represents an increase of 4.27% from it...
Fintel reports that on March 19, 2026, B. Riley Securities initiated coverage of FrontView REIT (NYSE:FVR) with a Buy recommendation. Analyst Price Forecast Suggests 4.27% Upside As of February 25, 2026, the average one-year price target for FrontView REIT is $16.90/share. The forecasts range from a low of $14.14 to a high of $19.95. The average price target represents an increase of 4.27% from its latest reported closing price of $16.21 / share. See our leaderboard of companies with the largest price target upside. The projected annual revenue for FrontView REIT is 73MM, an increase of 8.88%. The projected annual non-GAAP EPS is 0.12. What is the Fund Sentiment? There are 134 funds or institutions reporting positions in FrontView REIT. This is an decrease of 62 owner(s) or 31.63% in the last quarter. Average portfolio weight of all funds dedicated to FVR is 0.07%, an increase of 63.79%. Total shares owned by institutions increased in the last three months by 6.17% to 16,587K shares. What are Other Shareholders Doing? Zimmer Partners holds 920K shares representing 4.13% ownership of the company. In its prior filing, the firm reported owning 1,118K shares , representing a decrease of 21.50%. The firm increased its portfolio allocation in FVR by 8.11% over the last quarter. CI Private Wealth holds 761K shares representing 3.41% ownership of the company. In its prior filing, the firm reported owning 168K shares , representing an increase of 77.93%. The firm increased its portfolio allocation in FVR by 55.47% over the last quarter. Alyeska Investment Group holds 624K shares representing 2.80% ownership of the company. No change in the last quarter. FRESX - Fidelity Real Estate Investment Portfolio holds 553K shares representing 2.48% ownership of the company. No change in the last quarter. Geode Capital Management holds 515K shares representing 2.31% ownership of the company. In its prior filing, the firm reported owning 471K shares , representing an increase of 8.50%. ...
Earnings Call Insights: Snail, Inc. (SNAL) Q4 2025 Management View Peter Kang, Senior VP, highlighted that "the fourth quarter capped a pivotal year for Snail and the ARK franchise," noting milestones such as the launch of ARK: Lost Colony DLC and the introduction of a multiyear content pipeline for ASA. He stated, "we have not yet released a full-scale expansion pack that truly brought into the n...
Earnings Call Insights: Snail, Inc. (SNAL) Q4 2025 Management View Peter Kang, Senior VP, highlighted that "the fourth quarter capped a pivotal year for Snail and the ARK franchise," noting milestones such as the launch of ARK: Lost Colony DLC and the introduction of a multiyear content pipeline for ASA. He stated, "we have not yet released a full-scale expansion pack that truly brought into the narrative, game play depth or overall scope of the ASA experience to fully realize its long-term engagement potential. ARK: Lost Colony changed that trajectory." Kang reported presale demand for Lost Colony exceeded internal projections and that ASA surpassed 4 million units sold. Q4 performance included 692,000 ASA units sold, with a peak DAU of over 147,000, while ARK Mobile reached 10 million cumulative downloads. Management unveiled plans for four major ASA DLCs in 2026 and three in 2027, stating, "these 7 significant releases represent one of the most ambitious expansion cycles ever planned for ASA and provide snow with meaningful revenue visibility through 2027." Kang announced the upcoming release of ARK: World Creator, a content tool for both console and PC players, targeting a May rollout, followed by ARK: Bob's True Tales - Tides of Fortune in June and Dragontopia in December. He also introduced new indie and AAA titles, including Gobby Gang and Bellwright console ports, and shared that Bellwright surpassed 1 million units sold. Heidy Kingwan Chow, CFO, stated, "Net revenue for the fourth quarter was $25.1 million compared to $26.2 million in the same period last year... On a sequential basis, we are pleased to see Q4 net revenue increased 82% compared to $13.8 million in Q3 2025." Chow reported a Q4 net loss of $900,000, a significant improvement over the Q3 net loss of $7.9 million. She added, "Bookings for the fourth quarter increased to $20.8 million compared to $17 million in the same period last year." Outlook Kang indicated that the company is entering "a co...
Earnings Call Insights: electroCore, Inc. (ECOR) Q4 2025 Management View Daniel Goldberger, CEO, announced his decision to retire effective April 1, 2026, following a tenure focused on strengthening the company’s financial position, commercial strategy, and expansion in the VA channel. He stated, "I have made the decision to retire as CEO of electroCore effective April 1, 2026... With that foundat...
Earnings Call Insights: electroCore, Inc. (ECOR) Q4 2025 Management View Daniel Goldberger, CEO, announced his decision to retire effective April 1, 2026, following a tenure focused on strengthening the company’s financial position, commercial strategy, and expansion in the VA channel. He stated, "I have made the decision to retire as CEO of electroCore effective April 1, 2026... With that foundation now in place, the board and I believe this is the right time to begin a leadership transition as electroCore moves into its next stage of growth." The Board appointed CFO Joshua Lev as Interim President, and Michael Fox, formerly Chief Revenue Officer at ProMedTek, will join as Chief Operating Officer in April. Dr. Thomas Errico, Chairman, emphasized, "With this transition in place, the board and management team remains fully focused on executing our strategy of increasing sales within covered entities such as the VA system and driving long-term value through market expansion into general wellness with our Truvaga product offering." Dr. Errico highlighted clinical evidence supporting the gammaCore device and noted growing international and U.S. adoption, with expanding studies in new indications. CFO Joshua Lev stated, "electroCore delivered another year of strong top-line revenue growth, extending our growth trend and exceeding both revenue and EPS analyst consensus estimates. The VA hospital system remains our largest customer and continues to grow with the expanded adoption of our non-invasive pain therapeutics." Outlook Management expects full year 2026 revenue to continue growing at approximately 30%. CFO Lev explained, "we believe our full year 2026 revenue has the potential to continue growing at approximately 30%. Third quarter activity indicates continued adoption. However, in light of the leadership transition, we are not issuing detailed guidance at this time and expect to revisit formal guidance when appropriate." The company plans to expand applications for...
aapl Apple AAPL Stock Breaks Support and Slides Below $250 as Massive Costs and Delays Weigh Growing costs, product delays, and geopolitical threats have muddied the short-term outlook and put additional pressure on Apple shares. Written by: Skerdian Meta • • 3 min read • Quick overview Apple shares are facing renewed pressure due to rising costs, product delays, and geopolitical risks, falling be...
aapl Apple AAPL Stock Breaks Support and Slides Below $250 as Massive Costs and Delays Weigh Growing costs, product delays, and geopolitical threats have muddied the short-term outlook and put additional pressure on Apple shares. Written by: Skerdian Meta • • 3 min read • Quick overview Apple shares are facing renewed pressure due to rising costs, product delays, and geopolitical risks, falling below the $250 mark. The company announced a $100 billion investment in the U.S. as part of a broader $600 billion spending plan, raising concerns about capital efficiency. Recent product delays, particularly with the smart home display, have further impacted investor confidence and execution timelines. Despite these challenges, Apple's core financial performance remains strong, with significant revenue growth and a steady dividend. Live AAPL Chart AAPL 0.0000 MARKETS TREND [[AAPL-graph]] Growing costs, product delays, and geopolitical threats have muddied the short-term outlook and put additional pressure on Apple shares. Stock Under Pressure Amid Growing Concerns Shares of Apple Inc. have come under renewed pressure, falling below the $250 level as investor sentiment weakens. While the company remains fundamentally strong, markets are increasingly focused on near-term risks, including rising costs, delayed product launches, and geopolitical uncertainty. The recent pullback reflects a shift in focus from growth optimism to concerns about execution and profitability. Massive Investment Plans Raise Questions Apple recently announced a $100 billion investment in the United States, part of a broader $600 billion spending plan over the next four years. The initiative includes expanding manufacturing, increasing research and development, and hiring 20,000 employees across key areas such as software, silicon engineering, and machine learning. While the move underscores Apple’s long-term commitment to innovation and domestic production, investors have reacted cautiously. The scale o...
After losing the 2019 election when it pledged to renegotiate the Brexit deal and then hold a second referendum with Remain as an option, the party took the view it would be unable to regain power unless it reconnected with the many working-class voters who had traditionally voted Labour, but had then backed Leave in 2016 and supported Boris Johnson's call to "get Brexit done" in 2019.
After losing the 2019 election when it pledged to renegotiate the Brexit deal and then hold a second referendum with Remain as an option, the party took the view it would be unable to regain power unless it reconnected with the many working-class voters who had traditionally voted Labour, but had then backed Leave in 2016 and supported Boris Johnson's call to "get Brexit done" in 2019.
Entering a football match in England and Wales without a ticket will become a criminal offence under new laws that come into force before Sunday's Carabao Cup final between Arsenal and Manchester City at Wembley. Offenders will face a football banning order of up to five years, as well as a fine of up to £1,000. The legislation has been introduced as a result of the serious disorder that marred th...
Entering a football match in England and Wales without a ticket will become a criminal offence under new laws that come into force before Sunday's Carabao Cup final between Arsenal and Manchester City at Wembley. Offenders will face a football banning order of up to five years, as well as a fine of up to £1,000. The legislation has been introduced as a result of the serious disorder that marred the European Championship final between England and Italy at Wembley in July 2021, when thousands of fans forced their way into the stadium. The new act is designed to clamp down on 'tailgating' - where supporters without tickets make their way through turnstiles by staying close behind legitimate ticket-holders. It will also be illegal to knowingly attempt to gain entry using forged tickets, passes and accreditation documents, or by posing as a member of staff. Until now, there have been no specific legal penalties for entering a football match without a ticket, with supporters that are caught doing so tending to be ejected without any further punishment. "Football fans should be able to enjoy the game without feeling unsafe or threatened," said policing minister Sarah Jones. "We're giving the police the tools they need to ensure the chaos we saw at Wembley five years ago never happens again. "Anyone who endangers others by forcing their way into stadiums faces serious consequences." A Football Association (FA) commissioned report led by Baroness Louise Casey said the disorder at the Euro 2020 final could have led to deaths. It found that about 2,000 people got into the match illegally, with 17 mass breaches of disabled access gates and emergency fire doors. The Unauthorised Entry to Football Matches Act follows Baroness Casey's findings that sanctions on breaking into stadiums were weak, and that tailgating should become a criminal offence. Italy beat England on penalties in the final to be crowned European champions. England, Wales, Scotland and the Republic of Ireland are...